Peptides capable of modulating inflammatory heart disease

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 15 to 23 amino acid residues in defined sequence

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530327, 4241901, 4241851, A61K 3800, A61K 3804, A61K 3902, A61K 3900

Patent

active

059626364

ABSTRACT:
Disclosed are novel peptides that modulate inflammatory heart disease. Also disclosed are DNA molecules encoding the peptides, and methods of making the peptides.

REFERENCES:
patent: 5252714 (1993-10-01), Harris et al.
Penninger, J. M. et al. Cellular and molecular mechanisms of murine autoimmune myocarditis. APMIS v 105 pp. 1-13, Jan. 1997.
Allen, J.E. et al. Identification by sequence analysis of two-site postranslational processing of the cysteine-rich outer membrane protein 2 of Chlamydia trachomatis serovar L2. J. Bacteriol. vol. 171 pp. 285-291, Jan. 1989.
De La Maza, L.M. et al. Sequence diversity of the 60-kilodalton protein and of a putative 15-kilodalton protein between the trachoma and lymphogranuloma venerum biovars of Chlamydia trachomatis. Infection and Immunity v 59 pp. 1196-1201, Mar. 1991.
Watson, M.W. et al. The nucleotide sequence of the 60kDa cysteine rich outer membrane protein of Chlamydia pneumoniae strain IOL-207. Nucleic Acids Research vol. 18 p. 5299, 1990.
Watson, M.W. et al. The nucleotide sequence of the 60 kDa cysteine rich outer membrane protein of Chlamydia psittaci strain EAE/A22/M. Nucleic Acids Research vol. 18 p. 5300, 1990.
Hatt, C. et al. Analysis of the entire nucleotide sequence of the cryptic plasmid of Chlamydia tachomatis serovar L1: Evidence for involvement in DNA replication. Nucleic Acids Research v 16, pp. 4053-4067, 1988.
Ausubel et al., eds, Current Protocols in Molecular Biology, Green Publishers Inc. and Wiley and Sons, NY (1994) (Table of Contents Provided).
Ausubel et al., eds., "Metal-Chelate Affinity Chromatography", Current Protocols in Molecular Biology, Section 10.11.8, John Wiley & Sons, NY (1993).
Bodanszky, "Protection by Acylation", Principles of Peptide Synthesis, Springer-Verlag, New York p. 85 et seq. (1984).
Caruthers, "Gene Synthesis Machines: DNA Chemistry and Its Uses", Science, 230: 281-285 (1985).
Danesh et al., "Chronic infections and coronary heart disease: is there a link?", Lancet, 350: 430-436 (1997).
Davis et al., "CpG DNA Is a Potent Enhancer of Specific Immunity in Mice Immunized with Recombinant Hepatitis B Surface Antigen.sup.1 ", J. Immunol., 160: 870-876 (1998).
Dayhoff et al., Atlas of Protein Sequence and Structure,5, supp. 3 (1978) (Table of Contents Provided).
de la Maza et al., "Sequence Diversity of the 60-Kilodalton Protein and of a Putative 15-Kilodalton Protein between the Trachoma and Lymphogranuloma Venereum Biovars of Chlamydia trachomatis", Infect. Immun., 59: 1196-1201 (1991).
Engels et al., "Gene Synthesis", Angew. Chem. Intl. Ed., 28: 716-734 (1989).
Francis, "Protein modification and fusion proteins", Focus on Growth Factors, 3: 4-10 (1992).
Genbank Accession No. M76598.
Gennaro, ed., Remington's Pharmaceutical Sciences, 18.sup.th Edition, Mack Publishing Company (1990) (Table of Contents Provided).
Houghten et al., "General method for the rapid solid-phase synthesis of large numbers of peptides: Specificity of antigen-antibody interaction at the level of individual amino acids", Proc. Natl. Acad. Sci. USA, 82: 5132 (1985).
Kitts et al., "A Method for Producing Recombinant Baculovirus Expression Vectors at High Frequency", Biotechniques, 14: 810-817 (1993).
Lucklow et al., "Efficient Generation of Infectious Recombinant Baculoviruses by Site-Specific Transposon-Mediated Insertion of Foreign Genes into a Baculovirus Genome Propagated in Escherichia coli", J. Virol., 67: 4566-4579 (1993).
Lucklow, "Baculovirus systems for the expression of human gene products", Curr. Opin. Biotechnol., 4: 564-572 (1993).
Marshall et al, "Oligonucleotide synthesis as a tool in drug discovery research", Drug Discovery Today, 3: 34-42 (1998).
Marston et al., "Solubilization of Protein Aggregates", Meth. Enz., 182: 264-275 (1990).
Merrifield et al., "Solid Phase Peptide Synthesis. I. the Synthesis of a Tetrapeptide", J. AM. Chem. Soc., 85: 2149 (1963).
Messina et al., "Stimulation of In Vitro Murine Lymphocyte proliferation by Bacterial DNA.sup.1 ", J. Immunol, 147: 1759-1764 (1991).
Neu et al., "Cardiac Myosin Induces Myocarditis in Genetically Predisposed Mice.sup.1 ", J. Immunol., 139: 3630-3636 (1987).
Ossewaarde et al., "Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not", Epidemiol. and Infect., 120: 93-99 (1998).
Penninger et al., "A Genetic Map of Autoimmune Heart Disease", The Immunologist, 4: 131-141 (1996).
Pummerer et al., "Identification of Cardiac Myosin Peptides Capable of Inducing Autoimmune Myocarditis in BALB/c Mice", J. Clin. Invest., 97: 2057-2062 (1996).
Sambrook et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989) (Table of Contents Provided).
Stein et al., "Physicochemical properties of phosphorothioate oligodeoxynucleotides", Nuc. Acids Res., 16: 3209-3221 (1988).
Stewart and Young, Solid Phase Peptide Synthesis, Pierce Chemical Co., Rockford, IL (1984) (Table of Contents Provided).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Peptides capable of modulating inflammatory heart disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides capable of modulating inflammatory heart disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides capable of modulating inflammatory heart disease will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1172923

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.